Skin Cancer

News Skin Cancer

• Nanosensors support skin cancer therapy
  

  Malignant melanoma is the most aggressive type of skin cancer. In more than 50 percent of affected patients a particular mutation plays an important role. As the life span of the patients carrying the mutation can be significantly extended by novel drugs, it is very important to identify those relia more

• Melanoma-promoting gene discovered
  

  Black skin cancer, also known as melanoma, is particularly aggressive and becoming increasingly common in Switzerland. Despite intensive research, however, there is still no treatment. Researchers from the University of Zurich have now discovered a gene that plays a central role in black skin cancer more

• RNA regulator of melanoma could be a new target for cancer therapy

  Melanoma is the most deadly form of skin cancer, estimated by the National Cancer Institute to afflict more than 70,000 people in the United States annually and the incidence rate continues to rise.  In a study published in Genome Research, researchers have identified a previously unknown non-coding more

Publications Skin Cancer

• Chimeric negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated with melanoma, deafness and DNA repair deficiency

  ABSTRACT Melanoma is the most deadly form of skin cancer and DiGeorge syndrome (DGS) is the most frequent interstitial deletion syndrome. We characterized a novel balanced t(9;22)(p21;q11.2) translocation in a patient with melanoma, DNA repair deficiency, and features of DiGeorge syndrome (DGS) more

• Urinary levels of thymine dimer as a biomarker of exposure to ultraviolet radiation in humans during outdoor activities in the summer

  The incidence of skin cancer is rising rapidly in many countries, presumably due to increased leisure time exposure to solar ultraviolet radiation (UVR). UVR causes DNA lesions, such as the thymine dimer (T=T), which have been causatively linked to the development of skin cancer. T=T is clearly det more

• Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin

  Nicotinamide (vitamin B3) protects from ultraviolet (UV) radiation-induced carcinogenesis in mice and from UV-induced immunosuppression in mice and humans. Recent double-blinded randomized controlled Phase 2 studies in heavily sun-damaged individuals have shown that oral nicotinamide significantly more

Market studies Skin Cancer

• Nonmelanomatous Skin Cancer Global Clinical Trials Review, H1, 2012

  Introduction GlobalData's clinical trial report, “Nonmelanomatous Skin Cancer Global Clinical Trials Review, H1, 2012" provides data on the Nonmelanomatous Skin Cancer/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical tr more

• Nonmelanomatous Skin Cancer – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Nonmelanomatous Skin Cancer - Pipeline Review, H1 2012', provides an overview of the Nonmelanomatous Skin Cancer therapeutic pipeline. This report provides information on the therapeutic development for Nonmelanomatous Skin Cancer, complete with latest update more

• Galderma S.A. - Strategic SWOT Analysis Review

  Galderma S.A. - Strategic SWOT Analysis Review Summary Galderma S.A. (GSA) is one of the leading dermatology companies. The company provides therapeutic and aesthetic solutions for the treatment of major skin conditions such as acne, pigmentary disorders, skin cancers, rosacea, psoriasis / SRD (St more

Websites Skin Cancer